Here is what to gather before you leave: A copy of your prescription or a brief letter from your licensed healthcare provider confirming the medication is prescribed
Your dose may need to increase over time for continued weight loss, but your price remains flat at $189 per monthno surprise increases based on dose level
Studies in animal models showed that dual GIP/GLP-1 activation achieved more weight loss than GLP-1 activation by itself
But long-term chronic inflammation can cause enough damage to our body to lead to Parkinson's, Alzheimer's, other forms of dementia, and other "auto-immune" diseases such as MS
Adverse events 5% in SUSTAIN 5 8,10 AEs occurring in 5% of participants treated with Ozempic injection in SUSTAIN 5 Incidence of severe hypoglycemia was 1.5% across all placebo-controlled trials 1 Incidence of severe hypoglycemia or blood glucose-confirmed hypoglycemia (% of patients) was 8,10 : 8.3% with Ozempic injection 0.5 mg + basal insulin MET 10.7% with Ozempic injection 1 mg + basal insulin MET 5.3% with placebo + basal insulin MET Patients receiving Ozempic injection in combination with an insulin secretagogue (eg, sulfonylurea) or insulin may have an increased risk of hypoglycemia, including severe hypoglycemia 1 Adverse events 5% in SUSTAIN FORTE 4 AEs occurring in 5% of patients receiving Ozempic injection 1 mg and 2 mg in SUSTAIN FORTE In placebo-controlled trials, the most common adverse reactions reported in 5% of patients treated with Ozempic injection are nausea, vomiting, diarrhea, abdominal pain, and constipation 1 No new safety signals were identified
Consider waiting for retatrutide if: You have severe obesity (BMI 40) and specifically need the difference between 15% and 28%+ weight loss a gap that matters clinically when 15% still leaves you in a high-risk range
